Christa Broholm1, Anders H Olsson2, Alexander Perfilyev3, Ninna S Hansen2,4, Maren Schrölkamp2, Klaudia S Strasko2, Camilla Scheele4,5, Rasmus Ribel-Madsen2,6, Brynjulf Mortensen7, Sine W Jørgensen7, Charlotte Ling3, Allan Vaag2,4,7. 1. Department of Endocrinology, Diabetes and Metabolism, Rigshospitalet - Section 7652, Tagensvej 20, DK-2200, Copenhagen, Denmark. christa.broholm@gmail.com. 2. Department of Endocrinology, Diabetes and Metabolism, Rigshospitalet - Section 7652, Tagensvej 20, DK-2200, Copenhagen, Denmark. 3. Department of Clinical Sciences, Epigenetics and Diabetes, Lund University Diabetes Centre, CRC, Malmö, Sweden. 4. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 5. Centre of Inflammation and Metabolism, Rigshospitalet, Copenhagen, Denmark. 6. Danish Diabetes Academy, Odense, Denmark. 7. Steno Diabetes Center A/S, Gentofte, Denmark.
Abstract
AIMS/HYPOTHESIS: Low birthweight (LBW) is associated with dysfunctions of adipose tissue and metabolic disease in adult life. We hypothesised that altered epigenetic and transcriptional regulation of adipose-derived stem cells (ADSCs) could play a role in programming adipose tissue dysfunction in LBW individuals. METHODS: ADSCs were isolated from the subcutaneous adipose tissue of 13 normal birthweight (NBW) and 13 LBW adult men. The adipocytes were cultured in vitro, and genome-wide differences in RNA expression and DNA methylation profiles were analysed in ADSCs and differentiated adipocytes. RESULTS: We demonstrated that ADSCs from LBW individuals exhibit multiple expression changes as well as genome-wide alterations in methylation pattern. Reduced expression of the transcription factor cyclin T2 encoded by CCNT2 may play a key role in orchestrating several of the gene expression changes in ADSCs from LBW individuals. Indeed, silencing of CCNT2 in human adipocytes decreased leptin secretion as well as the mRNA expression of several genes involved in adipogenesis, including MGLL, LIPE, PPARG, LEP and ADIPOQ. Only subtle genome-wide mRNA expression and DNA methylation changes were seen in mature cultured adipocytes from LBW individuals. CONCLUSIONS/ INTERPRETATION: Epigenetic and transcriptional changes in LBW individuals are most pronounced in immature ADSCs that in turn may programme physiological characteristics of the mature adipocytes that influence the risk of metabolic diseases. Reduced expression of CCNT2 may play a key role in the developmental programming of adipose tissue.
AIMS/HYPOTHESIS: Low birthweight (LBW) is associated with dysfunctions of adipose tissue and metabolic disease in adult life. We hypothesised that altered epigenetic and transcriptional regulation of adipose-derived stem cells (ADSCs) could play a role in programming adipose tissue dysfunction in LBW individuals. METHODS: ADSCs were isolated from the subcutaneous adipose tissue of 13 normal birthweight (NBW) and 13 LBW adult men. The adipocytes were cultured in vitro, and genome-wide differences in RNA expression and DNA methylation profiles were analysed in ADSCs and differentiated adipocytes. RESULTS: We demonstrated that ADSCs from LBW individuals exhibit multiple expression changes as well as genome-wide alterations in methylation pattern. Reduced expression of the transcription factor cyclin T2 encoded by CCNT2 may play a key role in orchestrating several of the gene expression changes in ADSCs from LBW individuals. Indeed, silencing of CCNT2 in human adipocytes decreased leptin secretion as well as the mRNA expression of several genes involved in adipogenesis, including MGLL, LIPE, PPARG, LEP and ADIPOQ. Only subtle genome-wide mRNA expression and DNA methylation changes were seen in mature cultured adipocytes from LBW individuals. CONCLUSIONS/ INTERPRETATION: Epigenetic and transcriptional changes in LBW individuals are most pronounced in immature ADSCs that in turn may programme physiological characteristics of the mature adipocytes that influence the risk of metabolic diseases. Reduced expression of CCNT2 may play a key role in the developmental programming of adipose tissue.
Authors: Charlotte Brøns; Stine Jacobsen; Emma Nilsson; Tina Rönn; Christine B Jensen; Heidi Storgaard; Pernille Poulsen; Leif Groop; Charlotte Ling; Arne Astrup; Allan Vaag Journal: J Clin Endocrinol Metab Date: 2010-04-21 Impact factor: 5.958
Authors: Stine C Jacobsen; Linn Gillberg; Jette Bork-Jensen; Rasmus Ribel-Madsen; Ester Lara; Vincenzo Calvanese; Charlotte Ling; Agustin F Fernandez; Mario F Fraga; Pernille Poulsen; Charlotte Brøns; Allan Vaag Journal: Diabetologia Date: 2014-02-26 Impact factor: 10.122
Authors: Paula Dominguez-Salas; Sophie E Moore; Maria S Baker; Andrew W Bergen; Sharon E Cox; Roger A Dyer; Anthony J Fulford; Yongtao Guan; Eleonora Laritsky; Matt J Silver; Gary E Swan; Steven H Zeisel; Sheila M Innis; Robert A Waterland; Andrew M Prentice; Branwen J Hennig Journal: Nat Commun Date: 2014-04-29 Impact factor: 14.919
Authors: Mitsuteru Ito; Hui Shi; Kazuki Yamazawa; Elvira Isganaitis; Elizabeth J Radford; Jennifer A Corish; Stefanie Seisenberger; Timothy A Hore; Wolf Reik; Serap Erkek; Antoine H F M Peters; Mary-Elizabeth Patti; Anne C Ferguson-Smith Journal: Science Date: 2014-07-10 Impact factor: 47.728
Authors: Stephen M Ford; Liz Simon Peter; Paul Berner; Garth Cook; Curtis Vande Stouwe; Jason Dufour; Gregory Bagby; Steve Nelson; Patricia E Molina Journal: Am J Physiol Endocrinol Metab Date: 2018-07-24 Impact factor: 4.310
Authors: Tayaza Fadason; Cameron Ekblad; John R Ingram; William S Schierding; Justin M O'Sullivan Journal: Front Genet Date: 2017-10-13 Impact factor: 4.599